Filing Details
- Accession Number:
- 0001209191-21-036334
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-05-27 18:58:45
- Reporting Period:
- 2021-05-25
- Accepted Time:
- 2021-05-27 18:58:45
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1674930 | Fulgent Genetics Inc. | FLGT | Services-Medical Laboratories (8071) | 812621304 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1819718 | Jian Xie | C/O Fulgent Genetics, Inc. 4978 Santa Anita Ave., Ste 205 Temple City CA 91780 | Chief Operating Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2021-05-25 | 2,000 | $72.21 | 338,041 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The shares were sold in multiple transactions at prices ranging from $72.20 to $72.24, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.